FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23753 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)
Circulatory function test NOS Circulatory function tests
Circulatory function test NOS Circulatory function tests
Circumscribed scleroderma NOS Localised scleroderma
Cisapride 1mg/mL suspension Cisapride 1 mg/mL oral suspension
Cisplatin 50mg powder for infusion solution vial Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Cisplatin 50mg/vial powder for injection Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Citalopram hydrobromide 10mg/5mL solution Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Citrate 6.5% conventional release eye drops Citric acid only product
Citrate 6.5% preservative-free eye drops Citric acid only product
Citrate allergy Allergy to citric acid (finding)
Citrate monohydrate Citric acid monohydrate (substance)
Citric acid + potassium citrate + sodium citrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citric acid + sodium citrate 640mg/490mg Product containing citric acid and sodium citrate (medicinal product)
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citric acid monohydrate + potassium citrate + sodium citrate dihydrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citrobacter amalonaticus, biogroup 1 Citrobacter farmeri
Citrobacter diversus Citrobacter koseri
Citrullinemia, late-onset type Late-onset citrullinemia type I
Civil engineer NOS Civil engineer
Civil engineer NOS Civil engineer
Civil engineering equipment work NOS Civil engineer equipment work
Civil engineering equipment work NOS Civil engineer equipment work
Civil engineering technician (general) Civil engineering technician
Cladribine 1mg/mL infusion concentrate 10mL vial Cladribine 1 mg/mL solution for injection
Cladribine 1mg/mL injection Cladribine 1 mg/mL solution for injection
Cladribine 1mg/mL injection solution 10mL vial Cladribine 1 mg/mL solution for injection
Clam - dietary Clam (substance)
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack Amoxicillin 500 mg oral capsule
Class Actinobacteria Actinomycetes
Class Archaeobacteria Domain Archaea
Class Cestoidea - subclass cestoda Subclass Eucestoda (organism)
Class Chloroflexi Class Chloroflexia (organism)
Class Eurotiomycetes Subclass Eurotiomycetidae (organism)
Class Fibrobacteres Class Fibrobacteria
Class Lentisphaerae Class Lentisphaeria (organism)
Class Microsporea Phylum Microsporidia (organism)
Class amphibia Class Amphibia (organism)
Class arachnida Arachnid
Class crustacea Subphylum Crustacea (organism)
Class diplopoda Class Diplopoda (organism)
Classic SEMM laparoscopic hysterectomy Classic intrafascial supracervical hysterectomy (procedure)
Classic mast cell leukemia Mast cell leukemia (clinical)
Clavicular flap Flap (substance)
Clavulanate potassium + ticarcillin disodium gm/gm injection Product containing clavulanic acid and ticarcillin (medicinal product)
Clavulanate potassium gm/ticarcillin disodium gm injection solution vial Product containing clavulanic acid and ticarcillin (medicinal product)
Clay/stone worker NOS Clay/stone worker
Clay/stone worker NOS Clay/stone worker
Clean environment Clean environment (finding)
Cleaner for heated surfaces Cleaning agent (substance)
Cleaner for heated surfaces causing toxic effect Cleaning product causing toxic effect
Cleaning material Cleaning agent (substance)
Cleaning of skin wound NEC Cleaning of wound of skin (procedure)
Cleaning of skin wound NEC Cleaning of wound of skin (procedure)
Clear cell (mesonephroid) neoplasm - category Clear cell mesonephroid neoplasm
Clear cell sarcoma (except of Kidney M-89643) Clear cell sarcoma
Clemastine 1.34mg tablet Clemastine fumarate 1.34 mg oral tablet
Clemastine 500micrograms/5mL elixir Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine fumarate 0.67mg/5mL syrup Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemmys insculpta Glyptemys insculpta (organism)
Clindamycin 1% topical foam Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)
Clindamycin 1.2%/tretinoin 0.025% topical gel Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel
Clindamycin 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clindamycin 75mg/mL oral solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75 mg/ 5mL suspension Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75mg/5mL solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin phosphate 1% solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 100mg vaginal ovule Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug)
Clindamycin phosphate 10mg solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 10mg/mL solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress score Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score
Clinical X-ray application NOS Imaging (procedure)
Clinical X-ray application NOS Imaging (procedure)
Clinical actions A - G Action
Clinical actions A-O Action
Clinical actions H - O Action
Clinical actions P - S Action
Clinical actions P-Z Action
Clinical actions T - Z Action
Clinical allergy service Clinical allergy service
Clinical cytogenetics service Clinical cytogenetics service (qualifier value)
Clinical genetics service Clinical genetics service (qualifier value)
Clinical immunology service Clinical immunology service
Clinical management plan Clinical management plan
Clinical molecular genetics service Clinical molecular genetics service (qualifier value)
Clinical neurophysiology service Clinical neurophysiology service
Clinical sample finding Evaluation finding
Clinical stage 0 American Joint Committee on Cancer stage 0 (qualifier value)
Clinical stage I A American Joint Committee on Cancer stage IA (qualifier value)
Clinical stage I B American Joint Committee on Cancer stage IB (qualifier value)
Clinical stage I C American Joint Committee on Cancer stage IC (qualifier value)
Clinical stage I E American Joint Committee on Cancer stage IE (qualifier value)
Clinical stage I S American Joint Committee on Cancer stage IS (qualifier value)
Clinical stage II A American Joint Committee on Cancer stage IIA (qualifier value)
Clinical stage II B American Joint Committee on Cancer stage IIB (qualifier value)
Clinical stage II C American Joint Committee on Cancer stage IIC (qualifier value)
Clinical stage II E American Joint Committee on Cancer stage IIE (qualifier value)
Clinical stage III A American Joint Committee on Cancer stage IIIA (qualifier value)

Start Previous Page 38 of 238 Next End


Reference Sets

Reference set descriptor

Back to Start